UVB and UVA-1 Effects on HIV Activation

  • Ponciano D. CruzJr.

Abstract

Concern about safety of phototherapy for patients infected with the human immunodeficiency virus (HIV) exists because spread of the infection remains unabated, because HIV infection is associated with skin diseases responsive to phototherapy (including psoriasis, eosinophilic folliculitis, and pruritus), and because ultraviolet (UV) radiation has been shown to activate HIV and promote its proliferation.

Keywords

Psoriasis Stein Acetyl Chloramphenicol Collagenase 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1995; 228:800–802.Google Scholar
  2. (2).
    Valerie K, Delers A, Bruck C, Thiriart C, Rosenberg H, Debouck C et al. Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature 1988; 333:78–81.PubMedCrossRefGoogle Scholar
  3. (3).
    Stanley SK, Folks TM, Fauci AS. Induction of expression of human immunodeficiency virus in a chronically infected promonocytic cell line by ultraviolet irradiation. AIDS Res Hum Retroviruses 1989; 5:375–384.PubMedCrossRefGoogle Scholar
  4. (4).
    Zmudzka BZ, Strickland AG, Miller SA, Valerie K, Dall’Acqua F, Beer JZ. Activation of the human immunodeficiency virus promoter by UVA radiation in combination with psoralens or angelicins. Photochem Photobiol 1993; 58:226–232.PubMedCrossRefGoogle Scholar
  5. (5).
    Beer JZ, Olvey KM, Lee W, Zmudzka BZ. Reassessment of the differential effects of ultraviolet and ionizing radiation on HIV promoter: the use of cell survival as the basis for comparisons. Photochem Photobiol 1994; 59(6):643–649.PubMedCrossRefGoogle Scholar
  6. (6).
    Cavard C, Zider A, Vernet M, Bennoun M, Saragosti S, Grimber G et al. In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1 long terminal repeat. J Clin Invest 1990; 86:1369–1374.PubMedCrossRefGoogle Scholar
  7. (7).
    Morrey JD, Bourn SM, Bunch TD, Jackson MK, Sidwell RW, Barrows LR et al. In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. J Virol 1991;65(9):5045–5051.PubMedGoogle Scholar
  8. (8).
    Vogel J, Cepeda M, Tschachler E, Napolitano LA, Jay G. UV activation of human immunodeficiency virus gene expression in transgenic mice. J Virol 1992; 66(1):1–5.PubMedGoogle Scholar
  9. (9).
    Taher MM, Baumgardner T, Dent P, Valerie K. Genetic evidence that stress-activated p38 MAP kinase is necessary but not sufficient for UV activation of HIV gene expression. Biochem 1999; 38:13055–13062.CrossRefGoogle Scholar
  10. (10).
    Taher MM, Hershey CM, Oakley JD, Valerie K. Role of thep38 and MEK-l/2/p42/44 MAP kinase pathways in the differential activation of human immunodeficiency virus gene expression by ultraviolet and ionizing radiation. Photochem Photobiol 2000; 71(4):455–459.PubMedCrossRefGoogle Scholar
  11. (11).
    Taher MM, Oakley JD, Hershey CM, Valerie K. Activation of NF-κB and p38 MAP kinase is not sufficient for triggering efficient HIV gene expression in response to stress. Biochem 2000; 39:1709–1715.CrossRefGoogle Scholar
  12. (12).
    Stein B, Rahmsdorf HJ, Steffen A, Litfin M, Herrlich P. UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus Type 1, collagenase, c-fos, and metallothionein. Molecular & Cellular Biology 1989; 9:5169–5181.Google Scholar
  13. (13).
    Morison WL. Phototherapy and Photochemotherapy. New York: Raven Press, 1991.Google Scholar
  14. (14).
    Lim HW, Soter NA. Clinical Photomedicine. New York: Marcel Dekker, 1993.Google Scholar
  15. (15).
    Buchness MR, Lim HW, Hatcher VA, Sanchez M, Soter NA. Eosinophilic pustular folliculitis in the acquired immunodeficiency syndrome. N Eng J Med 1988; 318(18):1183–1186.CrossRefGoogle Scholar
  16. (16).
    Ranki A, Puska P, Mattinen S, Lagerstedt A, Krohn K. Effect of PUVA on immunologic and virologic findings in HIV-infected patients. J Am Acad Dermatol 24,404. 1991.PubMedCrossRefGoogle Scholar
  17. (17).
    Pardo RJ, Bogaert MA, Penneys NS, Byrne GE, Ruiz P. UVB phototherapy of the pruritic papular eruption of the acquired immunodeficiency syndrome. J Am Acad Dermatol 1992;26:423–428.PubMedCrossRefGoogle Scholar
  18. (18).
    Meola T, Soter NA, Ostreicher R, Sanchez M, Moy JA. The safety of UVB phototherapy in patients with HIV infection. J Am Acad Dermatol 1993; 29:216–220.PubMedCrossRefGoogle Scholar
  19. (19).
    Horn TD, Morison WL, Farzadegan H, Zmudzka BZ, Beer JZ. Effects of psoralen plus UVA radiation (PUVA) on HIV-1 in human beings: a pilot study. J Am Acad Dermatol 1994;31:735–740.PubMedCrossRefGoogle Scholar
  20. (20).
    Fotiades J, Lim HW, Jiang SB, Soter NA, Sanchez M, Moy J. Efficacy of ultraviolet B phototherapy for psoriasis in patients infected with human immunodeficiency virus. Photodermatol Photoimmunol Photomed 1995; 11:107–111.PubMedCrossRefGoogle Scholar
  21. (21).
    Fotiades J, Soter NA, Sanchez MR, Moy JA. A three-year follow-up evaluation on 28 HIV-positive patients treated with ultraviolet B (UVB) phototherapy. J Invest Dermatol 1995; 104:660a.Google Scholar
  22. (22).
    Breuer-McHam J, Marshall G, Adu-oppong A, Goller M, Mays S, Berger T et al. Alterations in HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapy. J Am Acad Dermatol 1999; 40(l):48–60.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Ponciano D. CruzJr.
    • 1
  1. 1.The University of Texas Southwestern Medical CenterDallas

Personalised recommendations